Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging-Ultrasound Fusion Targeted Biopsy: A Systematic Review.

[1]  M. Stifelman,et al.  A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial. , 2014, European urology.

[2]  Hans Garmo,et al.  Radical prostatectomy or watchful waiting in early prostate cancer. , 2014, The New England journal of medicine.

[3]  S. Verma,et al.  The feasibility of multiparametric magnetic resonance imaging for targeted biopsy using novel navigation systems to detect early stage prostate cancer: the preliminary experience. , 2013, Journal of endourology.

[4]  Monique J. Roobol,et al.  Defining the threshold for significant versus insignificant prostate cancer , 2013, Nature Reviews Urology.

[5]  A. Svindland,et al.  Detection of the index tumour and tumour volume in prostate cancer using T2‐weighted and diffusion‐weighted magnetic resonance imaging (MRI) alone , 2014, BJU international.

[6]  D. Moses,et al.  Multiparametric magnetic resonance imaging guided diagnostic biopsy detects significant prostate cancer and could reduce unnecessary biopsies and over detection: a prospective study. , 2014, The Journal of urology.

[7]  Shyam Natarajan,et al.  Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. , 2013, The Journal of urology.

[8]  R. Popert,et al.  V1266 MULTI-PARAMETRIC MRI - ULTRASOUND FUSION TARGETED BIOPSIES USING VARIAN BRACHYTHERAPY SOFTWARE: PRECISION PROSTATE CANCER DIAGNOSTICS , 2013 .

[9]  M. Gross,et al.  2185 MAGNETIC RESONANCE IMAGING TARGETED PROSTATE BIOPSY WITH 3-DIMENSIONAL ULTRASOUND TRACKING SYSTEM IN COMPARATIVE ANALYSIS TO SYSTEMATIC RANDOM BIOPSY ON 131 CONSECUTIVE PATIENTS WITH PRE-BIOPSY MAGNETIC RESONANCE IMAGING , 2013 .

[10]  Baris Turkbey,et al.  Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy. , 2014, The Journal of urology.

[11]  Zeike A. Taylor,et al.  MR to ultrasound registration for image-guided prostate interventions , 2012, Medical Image Anal..

[12]  B. Carey,et al.  Magnetic resonance imaging for the detection, localisation, and characterisation of prostate cancer: recommendations from a European consensus meeting. , 2011, European urology.

[13]  P. Walsh,et al.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.

[14]  Timothy J Wilt,et al.  Radical prostatectomy versus observation for localized prostate cancer. , 2012, The New England journal of medicine.

[15]  Jan van der Meulen,et al.  Multiparametric MR imaging for detection of clinically significant prostate cancer: a validation cohort study with transperineal template prostate mapping as the reference standard. , 2013, Radiology.

[16]  Mark Emberton,et al.  Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. , 2013, European urology.

[17]  Yipeng Hu,et al.  The PICTURE study -- prostate imaging (multi-parametric MRI and Prostate HistoScanning™) compared to transperineal ultrasound guided biopsy for significant prostate cancer risk evaluation. , 2014, Contemporary clinical trials.

[18]  M. Melamed,et al.  Identifying candidates for active surveillance: an evaluation of the repeat biopsy strategy for men with favorable risk prostate cancer. , 2012, The Journal of urology.

[19]  Baris Turkbey,et al.  Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. , 2013, European urology.

[20]  Tsuyoshi Mitake,et al.  Real‐time Virtual Sonography for navigation during targeted prostate biopsy using magnetic resonance imaging data , 2010, International journal of urology : official journal of the Japanese Urological Association.

[21]  P. P. Iu,et al.  ESUR prostate MR guidelines. , 2013, European radiology.

[22]  T. Peters,et al.  First Prize: A Phantom Model as a Teaching Modality for Laparoscopic Partial Nephrectomy , 2012 .

[23]  Eduard Baco,et al.  MRI and ultrasound-guided prostate biopsy using soft image fusion. , 2012, Anticancer research.

[24]  J. Kepner,et al.  A biomedical engineering approach to mitigate the errors of prostate biopsy , 2012, Nature Reviews Urology.

[25]  U. Capitanio,et al.  The role of transrectal saturation biopsy in tumour localization: pathological correlation after retropubic radical prostatectomy and implication for focal ablative therapy , 2011, BJU international.

[26]  J. Fütterer,et al.  Standards of reporting for MRI-targeted biopsy studies (START) of the prostate: recommendations from an International Working Group. , 2013, European urology.

[27]  J. J. de la Rosette,et al.  Global randomized narrow band imaging versus white light study in nonmuscle invasive bladder cancer: accession to the first milestone-enrollment of 600 patients. , 2013, Journal of endourology.

[28]  Theodorus H van der Kwast,et al.  A critical analysis of the tumor volume threshold for clinically insignificant prostate cancer using a data set of a randomized screening trial. , 2011, The Journal of urology.

[29]  Susan Mallett,et al.  QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies , 2011, Annals of Internal Medicine.

[30]  Xavier Leroy,et al.  Prostate cancer diagnosis: multiparametric MR-targeted biopsy with cognitive and transrectal US-MR fusion guidance versus systematic biopsy--prospective multicenter study. , 2013, Radiology.

[31]  A. Fenster,et al.  2031 ENHANCED TUMOUR SAMPLING AND GLEASON GRADING THROUGH FUSION OF MRI TO 3D TRANSRECTAL ULTRASOUND (TRUS) BIOPSY , 2012 .

[32]  Ian A. Donaldson,et al.  Multiparametric MRI followed by targeted prostate biopsy for men with suspected prostate cancer: a clinical decision analysis , 2014, BMJ Open.

[33]  Gaelle Fiard,et al.  Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusion. , 2013, Urology.

[34]  Shyam Natarajan,et al.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.

[35]  Naira Muradyan,et al.  Prebiopsy magnetic resonance imaging and prostate cancer detection: comparison of random and targeted biopsies. , 2013, The Journal of urology.

[36]  Pierre Mozer,et al.  First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography‐guided biopsies for the diagnosis of localised prostate cancer , 2015, BJU international.

[37]  Yujun Guo,et al.  Image Registration Accuracy of a 3‐Dimensional Transrectal Ultrasound–Guided Prostate Biopsy System , 2009, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.

[38]  M. Roethke,et al.  Definitions of terms, processes and a minimum dataset for transperineal prostate biopsies: a standardization approach of the Ginsburg Study Group for Enhanced Prostate Diagnostics , 2013, BJU international.

[39]  D. Moher,et al.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. , 2010, International journal of surgery.

[40]  Leonard S Marks,et al.  Target detection: magnetic resonance imaging-ultrasound fusion-guided prostate biopsy. , 2014, Urologic oncology.

[41]  P. Mozer,et al.  Validation of the European Society of Urogenital Radiology scoring system for prostate cancer diagnosis on multiparametric magnetic resonance imaging in a cohort of repeat biopsy patients. , 2012, European urology.

[42]  Hashim Uddin Ahmed,et al.  Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? , 2012, The Lancet. Oncology.

[43]  P. Choyke,et al.  Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation. , 2010, Radiology.

[44]  U. Kramer,et al.  1458 FUSION OF NON-CONTRAST-3TESLA-MRI AND TRUS-IMAGING: IMPLEMENTATION OF A NEW BIOPSY TECHNIQUE TO DETECT PROSTATE CANCER , 2012 .

[45]  A. Svindland,et al.  1061 Detection of the index tumor and tumor volume in prostate cancer using T2w and DW MRI alone , 2014 .

[46]  Theodore L. DeWeese,et al.  Localized Prostate Cancer , 2007 .

[47]  Heinz-Peter Schlemmer,et al.  Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer. , 2013, The Journal of urology.

[48]  J. Fütterer,et al.  ESUR prostate MR guidelines 2012 , 2012, European Radiology.

[49]  S. Vowler,et al.  Identification of pathologically insignificant prostate cancer is not accurate in unscreened men , 2014, British Journal of Cancer.

[50]  Maarten de Rooij,et al.  Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. , 2014, European urology.

[51]  Consumer Protection,et al.  European guidelines for quality assurance in breast cancer screening and diagnosis. Fourth edition--summary document. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[52]  A S Whittemore,et al.  Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer , 1993, Cancer.